EN
English
Anoro Ellipta 20 mcg
Added to your cart
59
Synflorix
Pneumococcal conjugate vaccine (Non-Typeable Haemophilus influenzae (NTHi) protein D, diphtheria or tetanus toxoid conjugates) adsorbed

EN
English
Anoro Ellipta 20 mcg
Added to your cart
59
Pneumococcal conjugate vaccine (Non-Typeable Haemophilus influenzae (NTHi) protein D, diphtheria or tetanus toxoid conjugates) adsorbed
Pneumococcal conjugate vaccine (Non-Typeable Haemophilus influenzae (NTHi) protein D, diphtheria or tetanus toxoid conjugates) adsorbed 1
SYNFLORIX helps protect children against pneumococcal disease.
SYNFLORIX is indicated for active immunization of infants and children from 6 weeks up to 5 years of age against diseases caused by Streptococcus pneumoniae serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F and cross-reactive 19A: 1
SYNFLORIX is part of the Quebec Immunization Program.2
Indications and clinical use:
SYNFLORIX is indicated for active immunization of infants and children from 6 weeks up to 5 years of age against diseases caused by Streptococcus pneumoniae serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F and cross-reactive 19A: 1
Not for use in adults.
Geriatrics (>65 years of age): Not studied.
Relevant warnings and precautions:
For more information:
Please consult the Product Monograph at
http://ca.gsk.com/media/591956/synflorix.pdf for important information relating to adverse reactions, drug interactions, and dosing information which have not been discussed in this piece.
The Product Monograph is also available by calling 1-800-387-7374.
Trademarks are owned by or licensed to the GSK group of companies.
© 2019 GSK group of companies or its licensor.